Effective component composition for improving emulsion stability and application thereof
Through the combination of 4-tert-butylcyclohexanol and ascorbic acid tetraisopalmitate, the problems of stability and whitening effect of low-viscosity emulsions are solved, and the preparation of emulsifier-free and low-viscosity emulsions is achieved, reducing safety risks and adverse skin Experience and show synergies in whitening.
Patent Information
- Application Number
- CN202411176882.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-26
- Publication Date
- 2024-11-26
- Estimated Expiration
- 2044-08-26
AI Technical Summary
It is difficult to achieve stability in the preparation process of existing low-viscosity emulsions. Emulsifiers or high-content rheology regulators are often required, resulting in potential safety risks and adverse skin feeling experiences, and it is difficult to meet the whitening effect.
The composition of 4-tert-butylcyclohexanol and ascorbic acid tetraisopalmitate is used as the effective component of an emulsifier-free and low-viscosity emulsion, improves emulsification stability and reduces the use of emulsifier and rheology regulators, while also having synergistic Improved whitening effect.
Without adding emulsifiers, a stable low-viscosity emulsion was prepared to reduce potential safety risks and adverse skin feeling experiences, and to show synergistic effects in whitening, achieving an appropriate viscosity range of 500 to 800 mPa·s. , suitable for a variety of cosmetics forms.
Smart Images

Figure CN119015166A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to an effective component composition for improving emulsification stability and application thereof, belonging to the technical field of cosmetics. Background Art
[0002] With the improvement of living standards, people pay more and more attention to skin protection, and the requirements for skin care products are also gradually increasing. They should not only be safe and effective, but also provide an extremely pleasant and comfortable skin experience. Conventional skin care lotions generally have a high viscosity, which makes it easy to feel thick and sticky on the skin and difficult to absorb. In recent years, low-viscosity emulsions have been widely used in cosmetics. They can replenish water and oil, and can well meet the needs of skin care effects such as moisturizing and nourishing. At the same time, they feel refreshing and easy to absorb, and will not add extra burden to the skin. It is one of the most popular dosage forms for consumers.
[0003] In the process of preparing low-viscosity emulsions, emulsifiers are generally used for dispersion in order to make the immiscible oil phase and water phase merge into a uniform mixture. However, the use of emulsifiers often poses safety risks, easily irritates human skin, and also gives the product an unpleasant skin feel such as stickiness, affecting the user experience. However, if emulsifiers are not added, it is difficult to obtain a stable emulsion, and emulsification failure or stability problems such as water and oil discharge and precipitation may occur after long-term storage.
[0004] Currently, there are stable emulsion products on the market without emulsifiers, but most of them are stabilized by adding high levels of rheology modifiers to stabilize the system with the help of the suspension and emulsification effects of rheology modifiers. However, a large amount of rheology modifiers will lead to a high viscosity of the system, which will not only give the product an undesirable skin feel such as stickiness and poor absorption, affecting the user experience, but will also impose certain restrictions on the choice of packaging materials and product forms. Therefore, the less rheology modifier is added, the better, while ensuring the stability of the system.
[0005] 4-tert-Butyl cyclohexanol is a specific member of the transient receptor potential vanilloid subtype 1 (TRPV-1), that is, an antagonist of the capsaicin receptor, which can effectively block the burning or tingling sensation caused by capsaicin, thereby effectively relieving skin discomfort.
[0006] Ascorbyl tetraisopalmitate is one of the ascorbic acid (vitamin C, VC) derivative family. It is obtained by the esterification reaction of two extra-long isopalmitic acid structures and the hydroxyl group of VC. It is an oil-soluble ingredient and is comparable to VC in terms of antioxidant and melanin inhibition, and is superior to VC in stability and mildness.
[0007] There is no related report on the improvement of emulsion stability by using 4-tert-butyl cyclohexanol and ascorbyl tetraisopalmitate in the prior art. Summary of the invention
[0008] In view of the deficiencies in the prior art, the present invention provides a functional ingredient composition for improving emulsion stability. The composition includes 4-tert-butyl cyclohexanol and ascorbyl tetraisopalmitate, has the ability to emulsify and suspend oil droplets, and can be used for the preparation of emulsifier-free, low-viscosity emulsion products. Without adding an emulsifier and with a low amount of rheology regulator added, a stable low-viscosity emulsion is prepared, thereby reducing the potential safety risks and adverse skin feel caused by emulsifiers and rheology regulators, and the two have a synergistic effect in whitening when used in combination.
[0009] The technical solution of the present invention is as follows:
[0010] A functional component composition for improving emulsion stability comprises 4-tert-butyl cyclohexanol and ascorbyl tetraisopalmitate.
[0011] Preferably, in the system containing the above composition, the final concentration of the 4-tert-butyl cyclohexanol is 0.3-0.6%, and the final concentration of the ascorbyl tetraisopalmitate is 0.1-1.0%, both of which are mass percentages.
[0012] Application of the above functional ingredient composition in the preparation of emulsifier-free, low-viscosity emulsion cosmetics.
[0013] Preferably, the final concentration of 4-tert-butyl cyclohexanol in the emulsion cosmetic is 0.3-0.6%, and the final concentration of ascorbyl tetraisopalmitate is 0.1-1.0%, both of which are mass percentages.
[0014] Preferably, the emulsion cosmetic further contains oil with a final concentration of 0.1 to 6.0%; more preferably, the emulsion cosmetic further contains oil with a final concentration of 3.0 to 6.0%, all of which are percentages by mass.
[0015] Further preferably, the oil includes but is not limited to isononyl isononanoate, caprylic / capric triglyceride, jojoba seed oil, squalane, polydimethylsiloxane, cyclopentasiloxane, C12-15 alcohol benzoate, dicaprylyl carbonate, ethylhexyl palmitate, triethylhexanoin, isododecane, and hydrogenated polyisobutene, or a combination of several thereof.
[0016] Preferably, the emulsion cosmetics may also contain other raw material ingredients permitted to be added in the cosmetics field, including but not limited to moisturizers, thickeners, preservatives, skin protectants, and the like.
[0017] In the present invention, the emulsion cosmetics can be obtained according to conventional cosmetic preparation processes.
[0018] Preferably, the emulsion cosmetic is in the form of essence, lotion, emulsion mask or emulsion disposable.
[0019] Preferably, the rotational viscosity of the emulsion cosmetic is 500 to 800 mPa·s.
[0020] An emulsifier-free, low-viscosity emulsion cosmetic containing the above-mentioned effective ingredient composition.
[0021] Preferably, the final concentration of 4-tert-butyl cyclohexanol in the emulsion cosmetic is 0.3-0.6%, and the final concentration of ascorbyl tetraisopalmitate is 0.1-1.0%, both of which are mass percentages.
[0022] Preferably, the emulsion cosmetic further contains oil with a final concentration of 0.1 to 6.0%; more preferably, the emulsion cosmetic further contains oil with a final concentration of 3.0 to 6.0%, all of which are percentages by mass.
[0023] Further preferably, the oil includes but is not limited to isononyl isononanoate, caprylic / capric triglyceride, jojoba seed oil, squalane, polydimethylsiloxane, cyclopentasiloxane, C12-15 alcohol benzoate, dicaprylyl carbonate, ethylhexyl palmitate, triethylhexanoin, isododecane, and hydrogenated polyisobutene, or a combination of several thereof.
[0024] Preferably, the emulsion cosmetics may also contain other raw material ingredients permitted to be added in the cosmetics field, including but not limited to moisturizers, thickeners, preservatives, skin protectants, and the like.
[0025] In the present invention, the emulsion cosmetics can be obtained according to conventional cosmetic preparation processes.
[0026] Preferably, the emulsion cosmetic is in the form of essence, lotion, emulsion mask or emulsion disposable.
[0027] Preferably, the rotational viscosity of the emulsion cosmetic is 500 to 800 mPa·s.
[0028] Beneficial effects:
[0029] (1) The present invention aims to solve the problem that adding emulsifiers to low-viscosity emulsion cosmetics will increase the risk of irritation, and it is difficult to achieve stability without adding emulsifiers. Adding a high content of rheology modifiers will lead to excessive viscosity and affect the skin feel experience. The inventors unexpectedly found that the combination of 4-tert-butyl cyclohexanol and ascorbyl tetraisopalmitate has the ability to emulsify and suspend oils and fats, and can improve the emulsion stability. It is possible to prepare a stable low-viscosity emulsion without adding an emulsifier and at a low amount of rheology modifier, thereby reducing the potential safety risks and adverse skin feel experience caused by emulsifiers and rheology modifiers, and has good market application prospects.
[0030] (2) The emulsifier-free, low-viscosity emulsion with a viscosity range of 500 to 800 mPa·s provided by the present invention has a relatively wide range of applications. In addition to conventional essence and emulsion products, it can also be used for products with more special forms, such as emulsion facial masks. If the viscosity of the emulsion facial mask material is too high, the mask cloth will not be evenly penetrated, and if the viscosity is too low, dripping will occur. 500 to 800 mPa·s is just the right viscosity. For another example, if it is applied to emulsion disposables, if the viscosity of the emulsion disposables is too high, it will be impossible to fill the emulsion. 500 to 800 mPa·s is a suitable filling viscosity.
[0031] (3) The combination of 4-tert-butyl cyclohexanol and ascorbyl tetraisopalmitate has a synergistic effect in whitening, which can achieve an effect of 1+1>2. BRIEF DESCRIPTION OF THE DRAWINGS
[0032] Figure 1 The graph is a centrifugal stability test result of the finished products of Examples 1 to 6 and Comparative Examples 1 to 3 and 7 after being centrifuged at 2000 r / min, 3000 r / min, and 4000 r / min for 30 minutes respectively. DETAILED DESCRIPTION
[0033] In order to better understand the present invention, the following is further described in conjunction with the embodiments, but the protection scope of the present invention is not limited to the following embodiments, and the embodiments should not be regarded as limiting the protection scope of the present invention.
[0034] The 4-tert-butyl cyclohexanol solution used in the examples and comparative examples is a mixed solution of 4-tert-butyl cyclohexanol and 1,2-pentanediol, wherein the content of 4-tert-butyl cyclohexanol is 37%, and it is sourced from Dezhixin Flavors & Fragrances (Nantong) Co., Ltd.; ascorbyl tetraisopalmitate is sourced from NIPPON SURFACTANT INDUSTRIES CO., LTD. The percentages of raw materials involved in the examples and comparative examples are all mass percentages.
[0035] Embodiment 1~6, comparative example 1~7:
[0036] A functional ingredient composition for improving emulsion stability, comprising 4-tert-butyl cyclohexanol and ascorbyl tetraisopalmitate. Examples 1 to 6 provide emulsions without emulsifiers and low viscosity containing the above-mentioned functional ingredient composition, and the raw material formula thereof is shown in Table 1. For comparison, Table 1 also provides the raw material formulas of emulsions of Comparative Examples 1 to 7. Comparative Examples 1 to 3 lack one or two of the functional ingredient compositions compared to Example 3; Comparative Examples 4 and 5 lack the functional ingredient composition compared to Example 3, and at the same time, add a common emulsifier respectively; Comparative Example 6 lacks the functional ingredient composition compared to Example 3, and at the same time increases the amount of rheology modifier added; Comparative Example 7 lacks 4-tert-butyl cyclohexanol compared to Example 3, and at the same time replaces an equal amount of 1,2-pentanediol. The total amount of oil (mainly present in phase A and phase B) added in the systems of Examples 1 to 6 and Comparative Examples 1 to 7 is the same.
[0037] Table 1. Raw material formula and addition amount of emulsions of Examples 1 to 6 and Comparative Examples 1 to 7, unit: wt%
[0038]
[0039]
[0040] Note: * indicates that, compared with Example 3, in Comparative Example 7, the 4-tert-butyl cyclohexanol solution is replaced by an equal amount of 1,2-pentanediol.
[0041] The preparation method of the emulsion comprises the following steps:
[0042] (1) Add the components of phase A into the oil phase tank in sequence, heat to 78±1°C, stir and melt to prepare phase A;
[0043] (2) Add water to an emulsification tank and heat it to 78±1°C; disperse the rheology modifier in dipropylene glycol to obtain a dispersion, then add the dispersion and the remaining raw materials of phase C to the emulsification tank, keep it warm at 78±1°C, stir and dissolve, and prepare phase C;
[0044] (3) Mix and stir the components of phase B evenly, and heat to 78±1°C to prepare phase B;
[0045] (4) Slowly add phase A to phase C, maintain 78±1°C, emulsify and homogenize for 5 minutes, then add phase B, emulsify and homogenize for 7 minutes until a uniform emulsion is formed, then cool with cooling water and add tromethamine at the same time;
[0046] (5) When the temperature drops to 67±1°C, add the components of phase D, stir to dissolve, and then continue to cool to room temperature to obtain an emulsion.
[0047] Embodiment 7~9, comparative example 8~10:
[0048] In order to avoid the influence of other ingredients such as oils and rheology regulators on the whitening efficacy test, Examples 7 to 9 only selected the functional ingredient compositions in the above embodiments for comparative testing of whitening efficacy. The functional ingredient composition formula is shown in Table 2. For comparison, Table 2 also provides comparative examples 8 to 10. Comparative examples 8 to 10 lack one component in the functional ingredient composition compared to Example 7.
[0049] Table 2. Raw material formula and addition amount of solutions of Examples 7 to 9 and Comparative Examples 8 to 10, unit: wt%
[0050]
[0051] Note: * indicates that, compared with Example 7, Comparative Example 10 is that the 4-tert-butyl cyclohexanol solution is replaced by an equal amount of 1,2-pentanediol.
[0052] Experimental example: performance test
[0053] The performance tests of the samples obtained in the above embodiments and comparative examples are as follows:
[0054] 1. Rotational viscosity test of samples obtained from Examples 1 to 6 and Comparative Examples 1 to 3 and 6
[0055] 1. Test method: After aging the sample for 24 hours, place it in a beaker, select a suitable rotor and immerse it in the sample, set the speed and time, start the test, and read and record the data after the test time is over.
[0056] 2. Test conditions: test temperature 25℃, rotor No. 04, speed 150RPM, test time 1min.
[0057] 3. Test results: The test results are shown in Table 3. The rotational viscosity of the samples obtained in Examples 1 to 6 is 500 to 800 mPa·s, and the viscosity value is relatively low; the rotational viscosity of the samples obtained in Example 3 and Comparative Examples 1 to 3 is not much different, indicating that the 4-tert-butyl cyclohexanol solution and ascorbic acid tetraisopalmitate and their compositions have little effect on the viscosity of the emulsion and can be used to prepare a low-viscosity system; Comparative Example 6 has a higher rotational viscosity due to the increased amount of rheology modifier added, which does not meet the viscosity requirements of the present invention.
[0058] Table 3. Rotational viscosity test results of finished products of Examples 1 to 6 and Comparative Examples 1 to 3 and 6, unit: mPa·s
[0059]
[0060] II. Particle size test of samples obtained in Examples 1 to 3, 5 and Comparative Examples 1 to 3, 7
[0061] 1. Test method: After the sample to be tested has been aged for 24 hours, add the sample to be tested into the laser particle size analyzer for testing and record the data.
[0062] 2. Test results: The test results are shown in Table 4. The average particle size of the samples obtained in Examples 1 to 3 and 5 is significantly smaller than that in Comparative Examples 1 to 3 and 7, indicating that the emulsified particle size of the emulsion after adding the functional ingredient composition is smaller and more evenly distributed, the emulsification effect is better, and the system is more stable. The average particle size of the samples obtained in Comparative Examples 1 and 2 is smaller than that in Comparative Example 3, but larger than that in Example 3, indicating that the 4-tert-butyl cyclohexanol solution and ascorbic acid tetraisopalmitate also have a certain emulsification effect when used alone, and the emulsification effect of the 4-tert-butyl cyclohexanol solution is stronger, but the effect is far less than that of the two when used in combination. The average particle size of the sample obtained in Comparative Example 7 is much larger than that in Example 3, and is close to that in Comparative Example 2, indicating that 1,2-pentanediol has no ability to improve the emulsification effect.
[0063] Table 4. Particle size test results of finished products of Examples 1 to 3, 5 and Comparative Examples 1 to 3, 7, unit: μm
[0064] Example 1 Example 2 Example 3 Example 5 Comparative Example 1 Comparative Example 2 Comparative Example 3 Comparative Example 7 Average particle size 4.382 5.816 5.094 5.146 6.041 8.866 9.683 8.371
[0065] III. Stability Test of Samples Obtained from Examples 1 to 6 and Comparative Examples 1 to 3 and 7
[0066] 1. Test method:
[0067] Centrifugal stability: The sample to be tested is allowed to stand at 38°C for one hour. The speed and time of the centrifuge are set. The samples are centrifuged at 2000r / min, 3000r / min, and 4000r / min for 30 minutes each. After centrifugation at different speeds, observe whether the samples will have stratification, water or oil out, and record the data.
[0068] Room temperature stability: Store the samples at room temperature for 3 months, observe whether the samples change color, delaminate, or release water or oil, and record the data.
[0069] Heat and cold resistance stability: Store the samples at constant temperatures of 45°C, 4°C, and -18°C for 3 months, observe whether the samples change color, delaminate, or release water or oil, and record the data.
[0070] Hot and cold cycle stability: Store the samples under hot and cold cycle conditions of -18℃, 4℃, and 45℃, with 3 days as one cycle. Store for one month, observe whether the samples will change color, delaminate, or release water or oil, and record the data.
[0071] 2. Test results: Centrifugal stability, room temperature stability, heat and cold resistance stability, and hot and cold cycle stability are commonly used methods to evaluate the stability of essences, emulsions and other dosage forms in cosmetics. Stability test results are as follows: Figure 1 As shown in Table 5 and Table 6, the finished products of Examples 1 to 6 all show good stability, and the centrifugal stability and room temperature, heat and cold resistance, and hot and cold cycle stability of the sample obtained in Example 3 are all stronger than those of Comparative Examples 1 to 3, indicating that the composition of 4-tert-butyl cyclohexanol solution and ascorbic acid tetraisopalmitate can improve the stability of the system. Although the centrifugal stability and room temperature, heat and cold resistance, and hot and cold cycle stability of the samples obtained in Comparative Examples 1 and 2 are stronger than those in Comparative Example 3, they are obviously not as good as those in Example 3, indicating that 4-tert-butyl cyclohexanol solution and ascorbic acid tetraisopalmitate have a positive effect on the stability of the system, but are obviously not as good as the combination of the two. The centrifugal stability and room temperature, heat and cold resistance, and hot and cold cycle stability of the sample obtained in Comparative Example 7 are far inferior to those in Example 3, and are close to those in Comparative Example 2, indicating that 1,2-pentanediol cannot improve the stability of the system.
[0072] Table 5. Centrifugal stability test results of finished products of Examples 1 to 6 and Comparative Examples 1 to 3 and 7
[0073]
[0074]
[0075] Note: √ indicates the sample is in normal condition, the same below.
[0076] Table 6. Test results of room temperature, heat and cold resistance, and hot and cold cycle stability of finished products of Examples 1 to 6 and Comparative Examples 1 to 3 and 7
[0077]
[0078] IV. Patch Test of Finished Products of Example 3 and Comparative Examples 4 and 5
[0079] 1. Test method: 30 volunteers were selected for each group. After the samples were aged for 24 hours, they were placed in the small chamber of the spot tester and then attached to the inner side of the left forearm of the volunteers for 24 hours. The spot tester was then removed and the skin reaction was observed.
[0080] 2. Test results: The test results are shown in Table 7. No adverse skin reaction was observed in the patch test of the sample obtained in Example 3. However, 3 cases of adverse reactions were observed in the volunteers of the samples of Comparative Examples 4 and 5 at 0.5 h, and 1 case of adverse skin reaction was observed in the volunteer of the sample of Comparative Example 5 at 24 h, indicating that the sample obtained in Example 3 is milder than Comparative Examples 4 and 5.
[0081] Table 7. Patch test results of finished products of Example 3 and Comparative Examples 4 and 5
[0082]
[0083]
[0084] V. Skin feel test of samples obtained from Example 3 and Comparative Examples 4 to 6
[0085] 1. Test method: Distribute the samples to be tested to 30 volunteers for trial use. After the trial use, evaluate the skin feel indicators of the samples using a scoring system.
[0086] Overall rating: 1 to 10 points, the higher the score, the better the overall skin feel;
[0087] Absorbability: 1 to 10 points, the higher the score, the better the absorbability;
[0088] Spreadability: 1 to 10 points, the higher the score, the better the spreadability;
[0089] Stickiness: 1 to 10 points, the higher the score, the stronger the stickiness;
[0090] Freshness: 1 to 10 points, the higher the score, the higher the freshness;
[0091] Skin-friendliness: 1 to 10 points, the higher the score, the better the skin-friendliness.
[0092] 2. Test results: The test results are shown in Table 8. Example 3 is superior to Comparative Examples 4 to 6 in terms of absorbency, skin affinity, stickiness and overall skin feel, indicating that not adding an emulsifier or reducing the addition of a rheology regulator in the formula can improve the skin feel of the emulsion.
[0093] Table 8. Skin feel test results of finished products of Example 3 and Comparative Examples 4 to 6
[0094] Skin feel index Example 3 Comparative Example 4 Comparative Example 5 Comparative Example 6 Overall 10 7 8 6 Absorbency 9 7 8 7 Spreadability 9 9 8 8 Sticky feeling 1 4 3 4 Freshness 9 7 8 7 Skin-friendly 10 8 7 7
[0095] VI. Whitening efficacy test of the compositions of Examples 7 to 9 and Comparative Examples 8 to 10
[0096] 1. Test method: Collect mouse skin melanoma cells B16-F10 with good growth status, prepare cell suspension with DMEM complete culture medium, and adjust the cell density to 1×10 5 / mL, add 5mL / bottle of cell suspension to T25 cell culture flask. The experimental groups were set up as blank control group (DMEM complete culture medium), negative control group (1μmol / Lα-MSH) and sample group (1μmol / Lα-MSH+Examples 7 to 9 / Comparative Examples 8 to 10), and each group was set up with 3 parallels. After adding the cell suspension, it was placed in a cell culture incubator (5% CO2, 37°C) and cultured for 24 hours. When the cell fusion rate reached about 60%, the culture medium was discarded, and DMEM complete culture medium was added to the blank control group, and DMEM complete culture medium containing 1μmol / Lα-MSH was added to the negative control group. DMEM complete culture medium containing 1μmol / Lα-MSH and the combination of Examples 7 to 9 / Comparative Examples 8 to 10 were added to the sample group. After being placed in a cell culture incubator for 24 hours, the original culture medium in the culture bottle was discarded, and the corresponding culture medium (same as above) was replaced according to the group, and the culture was continued for 48 hours. The culture medium was discarded, and 5×10 6 cells in an EP tube. Then, 400 μL of 1 mol / L NaOH solution (containing 10% DMSO) was added to each EP tube to resuspend the cells, and the cells were placed in an 80°C water bath for 2.5 hours. After centrifugation at 12000 r / min for 15 minutes, the cells were centrifuged again at 6000 r / min for 5 minutes. The supernatant was collected and 100 μL / well was added to a 96-well plate. Each group of samples had 3 replicates, and the OD value was measured at 475 nm using an enzyme reader. The relative melanin content was calculated based on the blank control group, and the melanin inhibition rate was further calculated:
[0097] Melanin inhibition rate = (relative to the average melanin content 阴性对照组 - Average relative melanin content 实施例 / 对比例 ) / average relative melanin content 阴性对照组 ×100%.
[0098] Among them, the test concentrations of the compositions of Examples 7 to 9 and Comparative Examples 8 to 10 are shown in Table 2. The 4-tert-butyl cyclohexanol solution and ascorbic acid tetraisopalmitate are first mixed in proportion and then dissolved in DMSO, and then diluted to the concentrations shown in Table 2 using DMEM complete culture medium as solvent.
[0099] 2. Test results: The test results are shown in Table 9. The melanin inhibition rates of Examples 7 to 9 are significantly higher than those of Comparative Examples 8 to 10, indicating that the combination of 4-tert-butyl cyclohexanol and ascorbyl tetraisopalmitate has a synergistic effect in whitening. The melanin inhibition rate of Comparative Example 10 is much lower than that of Example 7 and is very close to that of Comparative Example 9, indicating that 1,2-pentanediol has no whitening effect.
[0100] Table 9. Whitening efficacy test results of the compositions of Examples 7 to 9 and Comparative Examples 8 to 10
[0101]
[0102] In summary, the combination of 4-tert-butyl cyclohexanol and ascorbyl tetraisopalmitate can improve the emulsification stability and have a good emulsification effect. It can prepare a stable low-viscosity emulsion without adding an emulsifier and with a low amount of rheology modifier. The prepared emulsion is more gentle and has a better skin feel. In addition, the combination of 4-tert-butyl cyclohexanol and ascorbyl tetraisopalmitate also has a synergistic effect in whitening.
Claims
1. A functional ingredient composition for improving emulsion stability, characterized in that: These include 4-tert-butyl cyclohexanol and ascorbyl tetraisopalmitate.
2. The functional ingredient composition according to claim 1, characterized in that: In the system containing the above-mentioned effective ingredient composition, the final concentration of the 4-tert-butyl cyclohexanol is 0.3-0.6%, and the final concentration of the ascorbyl tetraisopalmitate is 0.1-1.0%, both of which are mass percentages.
3. Use of the functional ingredient composition according to claim 1 in the preparation of emulsifier-free, low-viscosity emulsion cosmetics.
4. The use according to claim 3, characterized in that The final concentration of 4-tert-butyl cyclohexanol in the emulsion cosmetic is 0.3-0.6%, and the final concentration of ascorbyl tetraisopalmitate is 0.1-1.0%, both of which are mass percentages.
5. The use according to claim 3, characterized in that The emulsion cosmetic further contains oil with a final concentration of 0.1 to 6.0%; further preferably, the emulsion cosmetic further contains oil with a final concentration of 3.0 to 6.0%, all in terms of mass percentage; Further preferably, the oil includes but is not limited to isononyl isononanoate, caprylic / capric triglyceride, jojoba seed oil, squalane, polydimethylsiloxane, cyclopentasiloxane, C12-15 alcohol benzoate, dicaprylyl carbonate, ethylhexyl palmitate, triethylhexanoin, isododecane, and hydrogenated polyisobutene, or a combination of several of them.
6. The use according to claim 3, characterized in that The emulsion cosmetics may also contain other raw materials allowed to be added in the cosmetics field, including moisturizers, thickeners, preservatives, and skin protectants; Preferably, the emulsion cosmetic is in the form of essence, lotion, emulsion mask or emulsion disposable; Preferably, the rotational viscosity of the emulsion cosmetic is 500 to 800 mPa·s.
7. An emulsifier-free, low-viscosity emulsion cosmetic containing the functional ingredient composition according to claim 1.
8. The emulsion cosmetic according to claim 7, characterized in that: The final concentration of 4-tert-butyl cyclohexanol in the emulsion cosmetic is 0.3-0.6%, and the final concentration of ascorbyl tetraisopalmitate is 0.1-1.0%, both of which are mass percentages.
9. The emulsion cosmetic according to claim 7, characterized in that: The emulsion cosmetic further contains oil with a final concentration of 0.1 to 6.0%; more preferably, the emulsion cosmetic further contains oil with a final concentration of 3.0 to 6.0%, all in terms of mass percentage; Further preferably, the oil includes but is not limited to isononyl isononanoate, caprylic / capric triglyceride, jojoba seed oil, squalane, polydimethylsiloxane, cyclopentasiloxane, C12-15 alcohol benzoate, dicaprylyl carbonate, ethylhexyl palmitate, triethylhexanoin, isododecane, and hydrogenated polyisobutene, or a combination of several thereof.
10. The emulsion cosmetic according to claim 7, characterized in that: The emulsion cosmetics may also contain other raw materials allowed to be added in the cosmetics field, including moisturizers, thickeners, preservatives, and skin protectants; Preferably, the emulsion cosmetic is in the form of essence, lotion, emulsion mask or emulsion disposable; Preferably, the rotational viscosity of the emulsion cosmetic is 500 to 800 mPa·s.
Citation Information
Patent Citations
Skin external-applying preparation based on quasi-ceramide and paeonol and production method thereof
CN106420605A
Composition for relieving pain and heat sensation in photoelectric surgery and preparation method and use of composition
CN112315863A
Application of myristyl nicotinate in cosmetics
CN116687793A
Self-emulsifying grease composition and application thereof in cosmetics
CN117045519A
Self-emulsifying composite solubilizing nano composition as well as preparation method and application thereof
CN117547477A
